Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics

ClinicalTrials.gov ID: NCT02382510

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02382510. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 12:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This multiple ascending dose study is to determine the safety and bronchodilator activity of TRN-157 in 59 mild and moderate asthmatics.

Study identification

NCT ID: NCT02382510
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Theron Pharmaceuticals, Inc.; Industry
Enrollment: 59 participants

Conditions and interventions

Conditions

Asthma

Interventions

TRN-157 Drug
Placebo Other
Tiotropium Drug

Drug · Other

Eligibility (public fields only)

Age range: 18 Years to 70 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 2015 (Type not available)
Primary completion: Mar 2016 (Actual)
Completion: Mar 2016 (Actual)
Last update posted: May 9, 2017

2015 – 2016

United States locations

U.S. sites: 7
U.S. states: 5
U.S. cities: 7

Facility	City	State	ZIP	Site status
WCCT Global	Costa Mesa	California	—	—
Allied Clinical Research	Gold River	California	95670	—
Allied Clinical Research	Reno	Nevada	89503	—
Dr. Winder & Associates/Toledo Center for Clinical Research	Sylvania	Ohio	—	—
The Allergy and Asthma Center of Southern Oregon	Medford	Oregon	—	—
West Houston Clinical Research Services	Houston	Texas	—	—
Sylvana Research	San Antonio	Texas	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02382510, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 9, 2017 · Synced Nov 13, 2026